Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

St. Joseph's HPV Self-sampling: Offering a Self-sampling Option in Clinic

NCT: NCT05092022 · ACTIVE_NOT_RECRUITING

NCT IDNCT05092022
StatusACTIVE_NOT_RECRUITING
Start Date2023-09-18
Completion2026-12-31
SponsorMilton S. Hershey Medical Center (OTHER)
First posted
Last updated

Brief Summary

This study aims to evaluate the effectiveness of offering self-sampled human papillomavirus (HPV) tests in increasing participation in cervical cancer screening, compared to the standard of care clinician-sampled test. The primary study endpoints are (1) patients' acceptability of self-sampled HPV tests vs. clinician-sampled test, and (2) patients' completion of self-sampled HPV test. The secondary study endpoint to be measured is the increase in cervical cancer screenings of any type in the PSH St. Joseph's residency clinic patient population.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑